Martin Daniel C.
Chief Commercial Officer at Deciphera Pharmaceuticals, Inc.
- Sold, on record
- $2.3M
- Dollars the filings state
- Form 4 sales
- 12
- Latest Feb 16, 2024
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Deciphera Pharmaceuticals, Inc.Chief Commercial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not statedFeb 16 2023
Sold 1,159 shares at $15.10 ($18k)
Martin Daniel C., Chief Commercial Officer
Sold 1.9% of holdings ($899k position)58,381 shares left0.9x usual sizeFiling
- 2 Form 4 sale Deciphera Pharmaceuticals, Inc.No planJun 16 +120 days
Sold 1,238 shares at $14.40 ($18k)
Martin Daniel C., Chief Commercial Officer
No 10b5-1 planSold 2.1% of holdings ($859k position)58,413 shares left1x usual sizeFiling
- 3 Form 4 sale Deciphera Pharmaceuticals, Inc.No planOct 30 +136 days
Sold 1,407 shares at $12.02 ($17k)
Martin Daniel C., Chief Commercial Officer
No 10b5-1 planSold 2.2% of holdings ($773k position)62,884 shares left1.1x usual sizeFiling
- 4 Form 144 notice Deciphera Pharmaceuticals, Inc.NoticeNov 30 +31 days
Filed to sell 17,801 shares ($224k)
Martin Daniel C., Officer
No 10b5-1 plan14x usual sizeFiling
- 5 Form 4 sale Deciphera Pharmaceuticals, Inc.UnusualNov 30 same day
Sold 17,801 shares at $12.57 ($224k)
Martin Daniel C., Chief Commercial Officer
No 10b5-1 planSold 28.2% of holdings ($795k position)45,435 shares left14x usual sizeFollows a Form 144Filing
- 6 Form 4 sale Deciphera Pharmaceuticals, Inc.No planDec 13 +13 days
Sold 1,727 shares at $15.37 ($27k)
Martin Daniel C., Chief Commercial Officer
No 10b5-1 planSold 3.4% of holdings ($784k position)49,284 shares left1.3x usual sizeFiling
- 7 Form 4 sale Deciphera Pharmaceuticals, Inc.No planJan 16 +34 days
Sold 1,624 shares at $14.47 ($23k)
Martin Daniel C., Chief Commercial Officer
No 10b5-1 planSold 3.3% of holdings ($713k position)47,660 shares left1.2x usual sizeFiling
- 8 Form 4 sale Deciphera Pharmaceuticals, Inc.No planFeb 16 +31 days
Sold 2,267 shares at $15.62 ($35k)
Martin Daniel C., Chief Commercial Officer
No 10b5-1 planSold 4% of holdings ($896k position)55,118 shares left1.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2024 | Deciphera Pharmaceuticals, Inc. | Chief Commercial Officer | Form 4 sale | 2,267 | $35k | 4.0% | No plan | SEC |
| Jan 16, 2024 | Deciphera Pharmaceuticals, Inc. | Chief Commercial Officer | Form 4 sale | 1,624 | $23k | 3.3% | No plan | SEC |
| Dec 13, 2023 | Deciphera Pharmaceuticals, Inc. | Chief Commercial Officer | Form 4 sale | 1,727 | $27k | 3.4% | No plan | SEC |
| Nov 30, 2023 | Deciphera Pharmaceuticals, Inc. | Chief Commercial Officer | Form 4 sale | 17,801 | $224k | 28.2% | Unusual | SEC |
| Nov 30, 2023 | Deciphera Pharmaceuticals, Inc. | Officer | Form 144 notice | 17,801 | $224k | Notice | SEC | |
| Oct 30, 2023 | Deciphera Pharmaceuticals, Inc. | Chief Commercial Officer | Form 4 sale | 1,407 | $17k | 2.2% | No plan | SEC |
| Jun 16, 2023 | Deciphera Pharmaceuticals, Inc. | Chief Commercial Officer | Form 4 sale | 1,238 | $18k | 2.1% | No plan | SEC |
| Feb 16, 2023 | Deciphera Pharmaceuticals, Inc. | Chief Commercial Officer | Form 4 sale | 1,159 | $18k | 1.9% | Plan not stated | SEC |
| Jan 17, 2023 | Deciphera Pharmaceuticals, Inc. | Chief Commercial Officer | Form 4 sale | 1,603 | $34k | 3.2% | Plan not stated | SEC |
| Jun 16, 2022 | Deciphera Pharmaceuticals, Inc. | Chief Commercial Officer | Form 4 sale | 1,311 | $14k | 2.6% | Plan not stated | SEC |
| Feb 16, 2022 | Deciphera Pharmaceuticals, Inc. | Chief Commercial Officer | Form 4 sale | 1,146 | $10k | 2.3% | Plan not stated | SEC |
| Jan 22, 2020 | Deciphera Pharmaceuticals, Inc. | Chief Commercial Officer | Form 4 sale | 26,999 | $1.8M | 61.4% | Unusual | SEC |
| Sep 19, 2019 | Deciphera Pharmaceuticals, Inc. | Chief Commercial Officer | Form 4 sale | 3,000 | $107k | 15.0% | Plan not stated | SEC |